首页> 外国专利> Assay for direct binding of peptides that are T-cell epitopes to MHC gene products on intact antigen-presenting cells and the use thereof for screening susceptibility of autoimmune diseases

Assay for direct binding of peptides that are T-cell epitopes to MHC gene products on intact antigen-presenting cells and the use thereof for screening susceptibility of autoimmune diseases

机译:将T细胞抗原决定簇的肽与完整抗原呈递细胞上的MHC基因产物直接结合的测定及其在自身免疫疾病易感性筛选中的用途

摘要

As assay for the measurement of direct binding of a peptide that is a T-cell epitope to gene products of the major histocompatibility complex (MHC), classes I and II, on the surface of intact living antigen- presenting cells, is provided. The assay comprises incubating the labelled peptide with the cells, and monitoring the extent of binding by the addition of a probe that reacts with the ligand used to label the peptide. The assay is suitable for autoimmune diseases and other immunological disorders. Peptides having a sequence corresponding to a stretch of the sequence of the antigen relevant to an immunological disorder, or modifications thereof, which bind to gene products of MHC, but do not stimulate T-cells, are also useful for the treatment of said disorders.
机译:作为用于测量T细胞表位的肽与主要组织相容性复合物(MHC)的基因产物在完整的活抗原呈递细胞表面上直接结合的测定方法,该方法为I类和II类。该测定包括将标记的肽与细胞一起孵育,并通过添加与用于标记肽的配体反应的探针来监测结合程度。该测定适用于自身免疫性疾病和其他免疫疾病。与MHC的基因产物结合但不刺激T细胞的,具有与免疫性疾病有关的抗原或其修饰的序列相对应的序列的肽也可用于治疗所述疾病。

著录项

  • 公开/公告号US5356779A

    专利类型

  • 公开/公告日1994-10-18

    原文格式PDF

  • 申请/专利权人 YEDA RESEARCH AND DEVELOPMENT CO. LTD.;

    申请/专利号US19900624730

  • 发明设计人 ISRAEL PECHT;EDNA MOZES;

    申请日1990-12-10

  • 分类号G01N33/564;G01N33/567;

  • 国家 US

  • 入库时间 2022-08-22 04:30:57

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号